EOM Pharmaceuticals Holdings, Inc.
$0.12+0.00%(+$0.00)
TickerSpark Score
26/100
20
Valuation
20
Profitability
40
Growth
20
Health
30
Momentum
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a IMUC research report →
52-Week Range26% of range
Low $0.04
Current $0.12
High $0.34
Companywww.eompharma.com
EOM Pharmaceuticals Holdings, Inc. is a clinical-stage biotechnology company, which engages in the development of drugs with the potential to transform therapeutic paradigms. Its pipeline includes EOM613 and EOM147.
- CEO
- Irach Taraporewala
- IPO
- 2021
- Employees
- 3
- HQ
- Montvale, NJ, US
Price Chart
+21.07% · this period
Valuation
- Market Cap
- $13.03M
- P/E
- -7.57
- P/S
- 0.00
- P/B
- -6.08
- EV/EBITDA
- -8.07
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 127.66%
- ROIC
- 287.57%
Growth & Income
- Revenue
- $0 · 0.00%
- Net Income
- $-1,922,557 · -1.61%
- EPS
- $-0.02 · 7.32%
- Op Income
- $-1,827,547
- FCF YoY
- 44.25%
Performance & Tape
- 52W High
- $0.34
- 52W Low
- $0.04
- 50D MA
- $0.13
- 200D MA
- $0.13
- Beta
- 0.20
- Avg Volume
- 3.57K
Get TickerSpark's AI analysis on IMUC
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 6, 18 | Yu John S | other | 120,000 |
| Dec 31, 16 | Gengos Andrew | other | 3,284 |
| Jun 17, 16 | Yu John S | other | 156,750 |
| Jun 17, 16 | Titus Gary | other | 156,750 |
| Jun 17, 16 | Singhvi Rahul | other | 156,750 |
| Jun 17, 16 | SCHLOSSBERG MARK A | other | 156,750 |
| Jun 17, 16 | LAPOINTE ANTHONY GREGG | other | 156,750 |
| Mar 11, 16 | Swanson Steven J | other | 150,000 |
| Mar 11, 16 | Swanson Steven J | other | 25,000 |
| Mar 11, 16 | FRACTOR DAVID | other | 100,000 |
Our IMUC Coverage
We haven't published any research on IMUC yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate IMUC Report →Similar Companies
SRBCF+0.00%
Sirona Biochem Corp.
$0.01
NYMXF+38.00%
Nymox Pharmaceutical Corporation
$0.10
HMTXF+0.00%
Hemostemix Inc.
$0.04
HOOK+0.00%
HOOKIPA Pharma Inc.
$1.19
LVCLF+0.00%
Algorae Pharmaceuticals Limited
$0.01
DVHGF+0.00%
Devonian Health Group Inc.
$10.65
PRVCF+21.77%
PreveCeutical Medical Inc.
$0.02
PPCB-12.22%
Propanc Biopharma, Inc.
$1.76